With the recent availability of a quadrivalent vaccine against Human papillomavirus (HPV), there has been a surge of published information about this infection in both the scientific and lay press. Medical-care providers desire more detailed information about HPV in order to answer the frequently-asked questions posed by their patients and their patient’s parents/guardians. It’s important to have a thorough and accurate understanding of the incidence/prevalence; risk factors for infection; pathophysiology; disease consequences of infection; updated screening guidelines for disease detection; and the latest information about HPV immunization including the Advisory Committee on Immunization Practices guidelines, efficacy in both viral-naïve and non-naïve populations, persistence of cross-neutralizing antibody levels, delayed anamnestic response to viral challenge and potential adverse events from vaccine.This article covers information that will enable you to diagnose, manage and prevent HPV infection in your patient population. Dr. W. David Hager, M.D., Women’s Care Center have discussed this in detail in our KentuckyDoc magazine.
